Item Type | Name |
Academic Article
|
Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors.
|
Academic Article
|
Transthoracic vertebrectomy for metastatic spinal tumors.
|
Academic Article
|
A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion.
|
Academic Article
|
The risk of second primary tumors after resection of stage I nonsmall cell lung cancer.
|
Academic Article
|
Video-assisted thoracoscopic versus open thoracotomy lobectomy in a cohort of 13,619 patients.
|
Academic Article
|
Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.
|
Academic Article
|
3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).
|
Academic Article
|
Superior sulcus tumors with vertebral body involvement: a multimodality approach.
|
Concept
|
Lung Neoplasms
|
Academic Article
|
Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease.
|
Academic Article
|
Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy.
|
Academic Article
|
Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population.
|
Academic Article
|
Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.
|
Academic Article
|
Early-stage pulmonary adenocarcinoma (T1N0M0): a clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Center Experience.
|
Academic Article
|
Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome.
|
Academic Article
|
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma.
|
Academic Article
|
EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
|
Academic Article
|
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing.
|
Academic Article
|
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.
|
Academic Article
|
A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax.
|
Academic Article
|
Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection.
|
Academic Article
|
Preoperative chemotherapy for lung cancer does not increase surgical morbidity.
|
Academic Article
|
Genetic and immunologic therapies for lung cancer.
|
Academic Article
|
Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.
|
Academic Article
|
Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR.
|
Academic Article
|
Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients.
|
Academic Article
|
Prognosis and reevaluation of lung cancer by positron emission tomography imaging.
|
Academic Article
|
Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer.
|
Academic Article
|
Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival.
|
Academic Article
|
Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma.
|
Academic Article
|
The role of PKR/eIF2a signaling pathway in prognosis of non-small cell lung cancer.
|
Academic Article
|
Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells.
|
Academic Article
|
Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.
|
Academic Article
|
Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.
|
Academic Article
|
Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.
|
Academic Article
|
Molecular events in bronchogenic carcinoma and their implications for therapy.
|
Academic Article
|
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53).
|
Academic Article
|
Gene therapy in lung cancer.
|
Academic Article
|
Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma.
|
Academic Article
|
P53 gene replacement for cancer--interactions with DNA damaging agents.
|
Academic Article
|
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
|
Academic Article
|
Imaging of the patient with non-small cell lung cancer.
|
Academic Article
|
Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53.
|
Academic Article
|
Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue.
|
Academic Article
|
Development of Ad-mda7/IL-24-resistant lung cancer cell lines.
|
Academic Article
|
Data driven semantic integration of translational lung cancer research at MDAnderson Cancer Center.
|
Academic Article
|
Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".
|
Academic Article
|
Non-small cell lung cancer resection in lymphoma patients.
|
Academic Article
|
Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters.
|
Academic Article
|
Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy.
|
Academic Article
|
Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis.
|
Academic Article
|
Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.
|
Academic Article
|
Tissue platinum concentration and tumor response in non-small-cell lung cancer.
|
Academic Article
|
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.
|
Academic Article
|
Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer.
|
Academic Article
|
Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells.
|
Academic Article
|
p53 tumor suppressor gene therapy for cancer.
|
Academic Article
|
Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells.
|
Academic Article
|
Gene replacement strategies for treating non-small cell lung cancer.
|
Academic Article
|
Gene therapy approaches for the management of non-small cell lung cancer.
|
Academic Article
|
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
|
Academic Article
|
Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model.
|
Academic Article
|
Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release.
|
Academic Article
|
The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells.
|
Academic Article
|
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
|
Academic Article
|
Positron emission tomography imaging in nonsmall-cell lung cancer.
|
Academic Article
|
Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer.
|
Academic Article
|
Double-stranded RNA-dependent protein kinase-dependent apoptosis induction by a novel small compound.
|
Academic Article
|
Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.
|
Academic Article
|
Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients.
|
Academic Article
|
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.
|
Academic Article
|
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
|
Academic Article
|
Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery.
|
Academic Article
|
Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.
|
Academic Article
|
Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC.
|
Academic Article
|
IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells.
|
Academic Article
|
Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy.
|
Academic Article
|
Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone".
|
Academic Article
|
Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.
|
Academic Article
|
Immunopathological features of human pulmonary tumors following low-dose interleukin-2.
|
Academic Article
|
Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR).
|
Academic Article
|
Clinical update of Ad-p53 gene therapy for lung cancer.
|
Academic Article
|
The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
|
Academic Article
|
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
|
Academic Article
|
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
|
Academic Article
|
Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients.
|
Academic Article
|
Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer.
|
Academic Article
|
Gene therapy for human lung cancers.
|
Academic Article
|
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
|
Academic Article
|
Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: activation of the mitochondria-dependent death-signaling pathway.
|
Academic Article
|
Sarcomatoid carcinoma of the lung: a predictor of poor prognosis.
|
Academic Article
|
Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival.
|
Academic Article
|
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.
|
Academic Article
|
Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer.
|
Academic Article
|
Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases.
|
Academic Article
|
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.
|
Academic Article
|
Optimizing surrogate end points for preoperative systemic therapies in non-small cell lung cancers.
|
Academic Article
|
Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma.
|
Academic Article
|
Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
|
Academic Article
|
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.
|
Academic Article
|
Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management.
|
Academic Article
|
Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.
|
Academic Article
|
RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer.
|
Academic Article
|
Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival.
|
Academic Article
|
Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults.
|
Academic Article
|
Predictive biomarkers in precision medicine and drug development against lung cancer.
|
Academic Article
|
Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients.
|
Academic Article
|
Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer.
|
Academic Article
|
SABR vs surgery for NSCLC in the media.
|
Academic Article
|
Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway.
|
Academic Article
|
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy
|
Academic Article
|
Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults
|
Academic Article
|
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers
|
Academic Article
|
Genomic heterogeneity of multiple synchronous lung cancer
|
Academic Article
|
Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells
|
Academic Article
|
The IASLC lung cancer staging project
|
Academic Article
|
Predictive biomarkers in precision medicine and drug development against lung cancer
|
Academic Article
|
Stage I lung cancer-to operate or to radiate? That is the question
|
Academic Article
|
Lung cancer
|
Academic Article
|
RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer
|
Academic Article
|
Accumulation of RNA-dependent protein kinase (PKR) in the nuclei of lung cancer cells mediates radiation resistance
|
Academic Article
|
Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.
|
Academic Article
|
RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer.
|
Academic Article
|
Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.
|
Academic Article
|
Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
|
Academic Article
|
Accumulation of RNA-dependent protein kinase (PKR) in the nuclei of lung cancer cells mediates radiation resistance.
|
Academic Article
|
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients.
|
Academic Article
|
Stage I lung cancer-to operate or to radiate? that is the question.
|
Academic Article
|
Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy.
|
Academic Article
|
Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.
|
Academic Article
|
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
|
Academic Article
|
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.
|
Academic Article
|
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
|
Academic Article
|
Genomic heterogeneity of multiple synchronous lung cancer.
|
Academic Article
|
Consolidative local therapy in oligometastatic patients - Authors' reply.
|
Academic Article
|
Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients.
|
Academic Article
|
DNA methylation intratumor heterogeneity in localized lung adenocarcinomas.
|
Academic Article
|
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.
|
Academic Article
|
Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.
|
Academic Article
|
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.
|
Academic Article
|
Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel.
|
Academic Article
|
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.
|
Academic Article
|
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.
|
Academic Article
|
Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
|
Academic Article
|
Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.
|
Academic Article
|
Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy.
|
Academic Article
|
Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.
|
Academic Article
|
Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer.
|
Academic Article
|
Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components.
|
Academic Article
|
Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy.
|
Academic Article
|
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
|
Academic Article
|
Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer.
|
Academic Article
|
Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.
|
Academic Article
|
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.
|
Academic Article
|
Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.
|
Academic Article
|
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.
|
Academic Article
|
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer.
|
Academic Article
|
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations.
|
Academic Article
|
Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women.
|
Academic Article
|
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.
|
Academic Article
|
Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC).
|
Academic Article
|
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
|
Academic Article
|
Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.
|
Academic Article
|
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC.
|
Academic Article
|
Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer.
|
Academic Article
|
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer.
|
Academic Article
|
Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.
|
Academic Article
|
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer.
|
Academic Article
|
Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease.
|
Academic Article
|
Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer.
|
Academic Article
|
Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm.
|
Academic Article
|
Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience.
|
Academic Article
|
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.
|
Academic Article
|
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.
|
Academic Article
|
Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization.
|
Academic Article
|
Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
|
Academic Article
|
Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
|
Academic Article
|
Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer.
|
Academic Article
|
Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients.
|
Academic Article
|
Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer.
|
Academic Article
|
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma.
|
Academic Article
|
Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding.
|
Academic Article
|
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization.
|
Academic Article
|
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
|
Academic Article
|
Comprehensive T cell repertoire characterization of non-small cell lung cancer.
|
Academic Article
|
High mutational concordance between primary colorectal tumors and associated pulmonary metastases.
|
Academic Article
|
Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
|
Academic Article
|
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer.
|
Academic Article
|
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy.
|
Academic Article
|
Making Checkpoint Inhibitors Part of Treatment of Patients With Locally Advanced Lung Cancers: The Time Is Now.
|
Academic Article
|
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.
|
Academic Article
|
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort.
|
Academic Article
|
Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients.
|
Academic Article
|
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC.
|
Academic Article
|
Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively.
|
Academic Article
|
Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers.
|
Academic Article
|
Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy.
|
Academic Article
|
Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC.
|
Academic Article
|
Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications.
|
Academic Article
|
Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
|
Academic Article
|
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.
|
Academic Article
|
STK11/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition.
|
Academic Article
|
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC.
|
Academic Article
|
Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target.
|
Academic Article
|
KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations.
|
Academic Article
|
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
|
Academic Article
|
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer.
|
Academic Article
|
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
|
Academic Article
|
Controversies and challenges in the pathologic examination of lung resection specimens after neoadjuvant treatment.
|
Academic Article
|
Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung?Cancer.
|
Academic Article
|
Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes.
|
Academic Article
|
Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.
|
Academic Article
|
Synchronous Esophageal and Lung Cancers-Is Combined Anatomic Resection Appropriate?
|
Academic Article
|
Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
|
Academic Article
|
Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer.
|
Academic Article
|
Modern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients.
|
Academic Article
|
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer.
|
Academic Article
|
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.
|
Academic Article
|
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.
|
Academic Article
|
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics.
|
Academic Article
|
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection.
|
Academic Article
|
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer.
|
Academic Article
|
Barriers to surveillance imaging adherence in early-staged lung cancer.
|
Academic Article
|
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC.
|
Academic Article
|
The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era.
|
Academic Article
|
Role of neoadjuvant chemoimmunotherapy for resectable NSCLC.
|
Academic Article
|
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.
|
Academic Article
|
Repeated Pulmonary Metastasectomy: Third?Operations and Beyond.
|
Academic Article
|
Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment.
|
Academic Article
|
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.
|
Academic Article
|
Intraoperative challenges after induction therapy for non-small cell lung cancer: Effect of nodal disease on technical complexity.
|
Academic Article
|
Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.
|
Academic Article
|
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.
|
Academic Article
|
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of?Recurrence in Stage I Non-Small Cell Lung Cancer.
|
Academic Article
|
Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection.
|
Academic Article
|
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
|
Academic Article
|
Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals.
|
Academic Article
|
Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery.
|
Academic Article
|
Financial Toxicity in Patients With Resected Lung Cancer.
|
Academic Article
|
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
|
Academic Article
|
Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy.
|
Academic Article
|
Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease.
|
Academic Article
|
Impact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer.
|
Academic Article
|
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.
|
Academic Article
|
Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
|
Academic Article
|
Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.
|
Academic Article
|
Circulomic variables predict pathologic staging preoperatively in treatment-na?ve non-small cell lung cancer.
|
Academic Article
|
Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer.
|
Academic Article
|
Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events.
|